Monday, November 22, 2010

Sadra Medical Acquired By Boston Scientific

Los Gatos-based Sadra Medical, a developer of a fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis, has been acquired by Boston Scientific, the firms said Friday afternoon. According to Boston Scientific, it will pay $225M upfront and up to $225M in additional poetntial payments upon achievement of certain regulatory and revenue-based milestones through 2016. Sadra's investors include Boston Scientific, Accuitive Medical Ventures, Finistere, Firstmark Capital, HealthCor Partners, Incept LLC, Oakwood, ONSET Ventures and SV Life Sciences.